Back

Exploring the risk of ventricular arrhythmia and sudden cardiac death with SGLT2 inhibitors in heart failure patients: a comprehensive systematic review and bayesian network meta-analysis

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Risk reduction for ventricular arrhythmias: revisiting knowns and unknowns Prevention ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Mohd Turzo Rahman

Flushing Hospital and Medical Center, Flushing (United States of America)

5 More presentations in this session

Presentation thumbnail
Competing risks of ventricular tachyarrhythmias and mortality in advanced heart failure: impact of left ventricular ejection fraction
Associate Professor A. Barsheshet (Petah Tikva, IL)
Abstract Slides Video
Presentation thumbnail
Impact of physical activity restriction in patients with arrhythmogenic dysplasia on the development of cardiovascular risk factors
Doctor A. Martinez Ballesta (Granada, ES)
Abstract Slides Video
Presentation thumbnail
Characteristics of high success rate antitachycardia pacing for ventricular tachycardia in implantable cardioverter-defibrillator recipients: true septal right ventricular lead position as a predictor
Doctor S. Yanagisawa (Nagoya, JP)
Abstract Slides Video
Presentation thumbnail
The quality of care and long-term mortality of patients with ST-elevation myocardial infarction and cardiac devices: a nationwide cohort study.
Doctor N. Weight (Stoke-on-Trent, GB)
Abstract Slides Video
Presentation thumbnail
Prophylactic catheter ablation in asymptomatic adult and pediatric patients with wolff-parkinson-white pattern: a systematic review and meta-analysis.
Doctor G. Dagostin de Carvalho (Sao Paulo, BR)
Abstract Slides Video

Access the full session

Session thumbnail
Risk reduction for ventricular arrhythmias: revisiting knowns and unknowns
Video

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Cardiovascular outcomes in diabetic patients treated with SGLT2i and GLP1-RA: systematic review and meta-analysis
thumbnail
Congress Presentation
Comparison of ventricular tachyarrhythmias in HF patients on dapagliflozin versus empagliflozin
thumbnail
Congress Presentation
Impact of SLGT2 inhibitors treatment initiation on the reduction of atrial and ventricular arrhythmias in patients with implanted cardiac defibrillator

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources